Q9ZE40 AF NFT

Uncharacterized lipoprotein RP108

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeici45xlhuqgee7n7mdip42p5mgd7nrrodz5j36lmgt3rj3qg7bc7y/metadata.json
IPFS of structure file: 
bafybeiao6pttzowsswofoui43zgotnyt46mg7vftzk3zfta3tetbrj47d4/AF-Q9ZE40-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xEa58c7534E5701aA8370E0fAEb19b7e14653e69c
First NFT owner address (bech32): 
genesis1afvvw56w2uq64qmsurawkxdhu9r98e5uajuhsx
Current NFT ID #504261 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
504261
Accession (UniProt):
Q9ZE40
Name::
Uncharacterized lipoprotein RP108
Experimental Method:
Predicted structure
Sequence source:
RICKETTSIA PROWAZEKII (STRAIN MADRID E)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q9ZE40 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q9ZE40|Y108_RICPR Uncharacterized lipoprotein RP108 OS=Rickettsia prowazekii (strain Madrid E) OX=272947 GN=RP108 PE=3 SV=1 MKKNIFITSLLILLLLLSSCTGDTCIDPDDFGFITFNVSSRYNPGEITSRHEGDQVTPWRDSAYKVNGYPLTIMVRPWNYILGDKNTSGQLSAWCPWYGQKNNTTTLAPFCVKLQPCTFWDNARFDMCTPNPENRNDAMISNPPCIMTDGVGLYFLIAAKNTDPNISPDSQRRPQGITKHLGELTSSVGYEFYSISSTGQFLKAGGINYQYNGEDKSKYAQSPLYFKIIDKFYDDNSGQYRLVIKSGVSDTRPDPLQFLTDLIKKVLFGKDGMIKKTYQQIIDTPGYKISVSAILTLYIMFTVLSFLIGNINLTHVELIIRIFKISIISILLSTDKAWTFFHDYLFVFFIDGVQQILQIINEAAATGPGSQSLLGLLISTQTLSKLFSLLFVDWLGFIYIILYLIALYFIFFLIFKATIIYLTALITIGMIIIMGPIFICFMLFNITRSLFENWLRQLISYALQPIILFAGIAFISMIIRTEIYSTLGFGVCKHDFPNLGPINEIFGSFLEDIDPSLGNSIFYWWFPVPMKGGINNFHKAKILVPNDHIVVDASCKNDHDKCKHCAAYECIDERYIELPFLDLVKDSTRINNFINGKFVQLDGILLIFVSIYLLSKFNDTAVSTAQFIAGTSGNLTDIQKVNQQSYESLSQQINRPLNYVAQAVSAPVTSRISAGTEQASMFFAEKFENMMMERLEKQALSSSANKAVQNEVKRKYGIDSKDVKMNAIKDYEDGISGLLKNLPKRNELKVKELSQMKFIQLRDKISANKYDVQDYAALSKEQKTELDKLLKDANLRALASEANFTKDYQEAYKQAHQEMSGRGIGLFGKNIGVLRSWQEMEHRVNVKRKLKEEKRIGIGEKIYAGYTGIKRAALTKILGKDLRDAYEGNLTSAEWHDFEYNDPRLRTYSEKLKDDEKAREYEELRMHINKETIAVQADILSPEYLVKLEKAGRQSDVEYYQGLAQKQLIHDVHSRLFEEGEPVMMGDRFMREKATDSQMRDMIDNAHKKYAELIDVDRYTRRQEYYDIIHEKAKENLEQTYKELKDHFKSDNISIEEMPSLIAQKVKDTNTGSEIDKKITEEINNFNTDVKNYEYSTAVLNKIEDRKQAIMNEVNAQIDKINKYRASAKMEQYVKPILNEGRKLRTLEDHLKNMT